Cardinal Health Reaffirms Fiscal 2024 non-GAAP EPS Guidance and Long-term Targets Amidst Nonrenewal of OptumRx Customer Contracts
Go back to Cardinal Health Reaffirms Fiscal 2024 non-GAAP EPS Guidance and Long-term Targets Amidst Nonrenewal of OptumRx Customer Contracts| Cardinal Health Inc. (NYSE: CAH) | Delayed: 228.91 +6.17 (2.77%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $222.74 | 52 Week High | $91.22 | |||
| Open | $225.21 | 52 Week Low | $62.70 | |||
| Day High | $229.26 | P/E | 213.93 | |||
| Day Low | $222.50 | EPS | $1.07 | |||
| Volume | 2,110,452 | |||||

